CD4 and neoplasm: In NSCLCs, the ectonucleotidase CD39 was found to be expressed on tumor cells, tumor-associated endothelial cells, as well as on cells of the immune systems including B-cells, regulatory and activated CD4+ or CD8+ T-cells, and innate immune cells [19,20].